Glucotrack (GCTK) Cash & Equivalents Growth (1y) (2011 - 2025)
Glucotrack (GCTK) Cash & Equivalents Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -19.91% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 21.89% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 5,969.23% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 78.03% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -14.50% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 5.06% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 19.45% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 21.40% |
| 10 | Glucotrack | 186,390.31 | -7.20 Mn | - | 31.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.44% |
| Mar 31, 2025 | 507.88% |
| Dec 31, 2024 | 25.04% |
| Sep 30, 2024 | -94.98% |
| Jun 30, 2024 | -98.19% |
| Mar 31, 2024 | 49.25% |
| Dec 31, 2023 | 94.29% |
| Sep 30, 2023 | 112.53% |
| Jun 30, 2023 | 127.66% |
| Mar 31, 2023 | -79.06% |
| Dec 31, 2022 | -61.86% |
| Sep 30, 2022 | -53.70% |
| Jun 30, 2022 | -51.17% |
| Mar 31, 2022 | -46.11% |
| Dec 31, 2021 | -38.29% |
| Sep 30, 2021 | -34.62% |
| Jun 30, 2021 | -31.45% |
| Mar 31, 2021 | -28.46% |
| Dec 31, 2020 | 2,244.39% |
| Sep 30, 2020 | 775.96% |